Therapeutic observations with Tavegyl.
D000328:Adult; D002974:Clemastine / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008297:Male; D011759:Pyrrolidines / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D011759:Pyrrolidines; D002974:Clemastine